Citation 125001

SAHPAZ,S: BORIES,CH: LOISEAU,PM: CORTES,D: HOCQUEMILLER,R: LAURENS,A: CAVE,A:. (1994). CYTOTOXIC AND ANTIPARASITIC ACTIVITY FROM ANNONA SENEGALENSIS SEEDS.. 60(6)

Citation Details

TitleCYTOTOXIC AND ANTIPARASITIC ACTIVITY FROM ANNONA SENEGALENSIS SEEDS.
AuthorsSAHPAZ,S: BORIES,CH: LOISEAU,PM: CORTES,D: HOCQUEMILLER,R: LAURENS,A: CAVE,A:
Year1994
Volume60
Issue6

Summary

Year: 1994

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
VINCALEUKOBLASTINE
STRONG ACTIVITY
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
VINCALEUKOBLASTINE
WEAK ACTIVITY

Annona senegalensis (ANNONACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
None
EQUIVOCAL
2
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
None
INACTIVE
3
ANTITRYPANOSOMAL ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
None
INACTIVE
4
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
None
ACTIVE
5
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
None
EQUIVOCAL
6
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
None
INACTIVE
7
ANTITRYPANOSOMAL ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
None
EQUIVOCAL
8
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
None
ACTIVE
9
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
None
EQUIVOCAL
10
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
None
EQUIVOCAL
11
ANTITRYPANOSOMAL ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
None
EQUIVOCAL
12
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
None
ACTIVE
13Not specified
ISOLATION AND IDENTIFICATION OF
SENEGALENE
None
14
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
SENEGALENE
ACTIVE
15
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
SENEGALENE
ACTIVE
16
ANTITRYPANOSOMAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
SENEGALENE
ACTIVE
17
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SENEGALENE
STRONG ACTIVITY
18
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SENEGALENE
ACTIVE
19Not specified
ISOLATION AND IDENTIFICATION OF
SQUAMOCIN
None
20
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SQUAMOCIN
STRONG ACTIVITY
21
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SQUAMOCIN
STRONG ACTIVITY
22
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
SQUAMOCIN
WEAK ACTIVITY
23
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
SQUAMOCIN
ACTIVE
24
ANTITRYPANOSOMAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
SQUAMOCIN
INACTIVE
25Not specified
ISOLATION AND IDENTIFICATION OF
ASIMICIN
None
26
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ASIMICIN
STRONG ACTIVITY
27
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ASIMICIN
STRONG ACTIVITY
28
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ASIMICIN
EQUIVOCAL
29
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ASIMICIN
EQUIVOCAL
30
ANTITRYPANOSOMAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ASIMICIN
INACTIVE
31Not specified
ISOLATION AND IDENTIFICATION OF
ROLLINIASTATIN 2
None
32
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ROLLINIASTATIN 2
STRONG ACTIVITY
33
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ROLLINIASTATIN 2
STRONG ACTIVITY
34
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ROLLINIASTATIN 2
EQUIVOCAL
35
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ROLLINIASTATIN 2
INACTIVE
36
ANTITRYPANOSOMAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ROLLINIASTATIN 2
INACTIVE
37Not specified
ISOLATION AND IDENTIFICATION OF
MOLVIZARIN
None
38
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MOLVIZARIN
STRONG ACTIVITY
39
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MOLVIZARIN
STRONG ACTIVITY
40
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLVIZARIN
ACTIVE
41
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLVIZARIN
WEAK ACTIVITY
42
ANTITRYPANOSOMAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLVIZARIN
EQUIVOCAL
Show SPARQL Queries (1)